Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,479 across all filing types
Latest filing 2026-03-06 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from "Telso" AD under Regulation 596/2014 for the acquisition of warrants with ISIN ą BG9200001253
Director's Dealing Classification · 100% confidence The document is a formal 'Notification of Insiders' Transactions' filed under Article 19 of Regulation (EU) No 596/2014 (MAR). It details a specific transaction (acquisition of warrants) by a person closely associated with a member of the Board of Directors of 'Sopharma' AD. This aligns perfectly with the definition of 'Director's Dealing' (DIRS), which covers reports of personal share or financial instrument transactions by company directors and their closely associated persons.
2026-03-06 English
Notification from Ognian Donev under Regulation 596/2014 for the acquisition of warrants with ISIN ą BG9200004257
Director's Dealing Classification · 100% confidence The document is a formal notification of an insider transaction under Article 19 of Regulation (EU) No 596/2014 (MAR). It details a transaction by Ognian Donev, an Executive Director of 'Sopharma' AD, involving the acquisition of warrants. This fits the definition of a Director's Dealing (DIRS) report, which covers personal share or financial instrument transactions by company directors and executives.
2026-03-06 English
Notification from "Donev investments holding" under Regulation 596/2014 for the acquisition of warrants with ISIN ą BG9200004257
Director's Dealing Classification · 100% confidence The document is a formal notification of an insider transaction under Article 19 of Regulation (EU) No 596/2014 (MAR). It details a transaction involving a person discharging managerial responsibilities (PDMR) or a person closely associated with them, specifically 'Donev investments holding' AD, regarding the acquisition of warrants in 'Sopharma' AD. This fits the definition of a Director's Dealing (DIRS) filing.
2026-03-06 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the sale of treasury shares by 'Sopharma' AD. It specifies the number of shares sold, the percentage of share capital, the transaction value, and the resulting total of treasury shares held. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or sales of treasury shares.
2026-03-06 English
Notification from "Donev investments holding" under Regulation 596/2014 for the acquisition of warrants with ISIN ą BG9200001253
Director's Dealing Classification · 100% confidence The document is a formal 'Notification of Insiders' Transactions' filed under Article 19 of Regulation (EU) No 596/2014 (MAR). It details a transaction involving a person closely associated with a person discharging managerial responsibilities (PDMR) at 'Sopharma' AD. This specific regulatory disclosure format is standard for reporting insider dealings, which corresponds to the 'Director's Dealing' category.
2026-03-05 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the sale of treasury shares by 'Sopharma' AD. It explicitly details the number of shares sold, the transaction date, the price, and the resulting change in the company's treasury share holdings. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or sales of treasury shares.
2026-03-05 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.